Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience

Blood Cancer J. 2023 Dec 20;13(1):191. doi: 10.1038/s41408-023-00963-y.

Affiliations

¹ Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA. sara.a.scott@emoryhealthcare.org.
² Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.

^# Contributed equally.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Cytokine Release Syndrome*
Cytokines*
Humans

Substances

tocilizumab
Cytokines
Antibodies, Monoclonal, Humanized